Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose 131I-MIBG in Tandem HDCT/ASCT for High-risk Neuroblastoma
NCT03061656Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jan 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Iobenguane I-131 in neuroblastoma, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
Iobenguane I-131
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT03061656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03061656.